A brutal diagnosis of Alzheimer’s disease has led to US neurologist Dr Daniel Gibbs participating in five clinical trials, coauthoring a case report on his atypical reaction to an amyloid aggregate‐targeting antibody, and writing a memoir. In a compelling Perspective piece in JAMA, Dr Gibbs said he has also become an advocate for early diagnosis ...
Neurologist with Alzheimers: ‘running off cognitive reserve’
By Mardi Chapman
3 May 2021